Skip to Content

LCE 125 (Carbidopa, Entacapone and Levodopa 31.25 mg / 200 mg / 125 mg)

Pill with imprint LCE 125 is Red, Elliptical / Oval and has been identified as Carbidopa, Entacapone and Levodopa 31.25 mg / 200 mg / 125 mg. It is supplied by Sandoz Inc.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 31.25 mg / 200 mg / 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 125

Carbidopa, Entacapone and Levodopa

Imprint:
LCE 125
Strength:
31.25 mg / 200 mg / 125 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Inc
National Drug Code (NDC):
00781-5641

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide